Journal of Forensic and Legal Medicine
Volume 17, Issue 6 , Pages 333-338 , August 2010

Drug-facilitated sexual assault in Ontario, Canada: Toxicological and DNA findings

  • Janice Du Mont, EdD (Research Scientist, Associate Professor)

      Affiliations

    • Women’s College Research Institute, Women’s College Hospital, Toronto, Canada
    • Department of Public Health Sciences, University of Toronto, Toronto, Canada
    • Corresponding Author InformationCorrespondence: Women’s College Research Institute, 790 Bay Street, 7th Floor, Toronto, Ontario M5G 1N8, Canada. Tel: +1 416 351 3732x2705; fax: +1 416 351 3746.
    • ,
  • Sheila Macdonald, MN (Provincial Coordinator)

      Affiliations

    • Ontario Network of Sexual Assault/Domestic Violence Treatment Centres, Toronto, Canada
    • ,
  • Nomi Rotbard, MPH (Research Associate, PhD Student)

      Affiliations

    • Women’s College Research Institute, Women’s College Hospital, Toronto, Canada
    • Mailman School of Public Health, Columbia University, NY, USA
    • ,
  • Deidre Bainbridge, BSc (Nurse Practitioner)

      Affiliations

    • Sexual Assault and Domestic Violence Care Centre, Women’s College Hospital, Toronto, Canada
    • ,
  • Eriola Asllani, BSc (Data Analyst)

      Affiliations

    • Women’s College Research Institute, Women’s College Hospital, Toronto, Canada
    • ,
  • Norman Smith, PhD (Associate Professor)

      Affiliations

    • Therapeutic Drug Monitoring & Toxicology, Clinical Biochemistry, St. Joseph's Health Care, London, Canada
    • Department of Biochemistry, University of Western Ontario, London, Canada
    • ,
  • Marsha M. Cohen, MD (Research Scientist, Professor)

      Affiliations

    • Women’s College Research Institute, Women’s College Hospital, Toronto, Canada
    • Department of Health Policy, Management & Evaluation, University of Toronto, Toronto, Canada

Received 6 July 2009 ,Revised 2 March 2010 ,Accepted 13 May 2010.

References 

  1. Anglin D, Spears KL, Hutson HR. Flunitrazepam and its involvement in date or acquaintance rape. Acad Emerg Med. 1997;4:323–326
  2. ElSohly M, Salamone S. Prevalence of drugs used in cases of alleged sexual assault. J Anal Toxicol. 1999;23:141–146
  3. Jamieson MA. Rohypnol, gamma hydroxybutyrate, and drug rape. J Soc Obstet Gynaecol Can. 2001;23:38–42
  4. Schwartz RH, Weaver AB. Rohypnol, the date rape drug. Clin Pediatr. 1998;37:321
  5. Waltzman ML. Flunitrazepam: a review of "roofies". Pediatr Emerg Care. 1999;15:59–60
  6. Weir E. Drug-facilitated date rape. CMAJ. 2001;165:80
  7. McGregor MJ, Lipowska M, Shah S, Du Mont J, De Siato C. An exploratory analysis of suspected drug-facilitated sexual assault seen in a hospital emergency department. Womens Health. 2003;37:71–80
  8. Dorandeu AH, Pagès CA, Sordino M-C, Pépin G, Baccino E, Kintz P. A case in south-eastern France: a review of drug facilitated sexual assault in European and English-speaking countries. J Clin Forensic Med. 2006;13:253–261
  9. Hindmarch I, Brinkmann R. Trends in the use of alcohol and other drugs in cases of sexual assault. Hum Psychopharm Clin Exp. 1999;14:225–231
  10. Mullins ME. Laboratory confirmation of flunitrazepam in alleged cases of date rape. Emerg Med J. 1999;6:966–968
  11. Slaughter L. Involvement of drugs in sexual assault. J Reprod Med. 2000;45:425–430
  12. Hindmarch I, ElSohly M, Gambles J, Salamone S. Forensic urinalysis of drug use in cases of alleged sexual assault. J Clin Forensic Med. 2001;8:197–205
  13. Sturman P. Drug assisted sexual assault: a study for the Home Office under the Police Research Award Scheme. London, United Kingdom: Home Office; 2000;
  14. Women’s Health Strategy Unit . Protocol: a coordinated approach to better respond to drug-facilitated sexual assault in Darwin urban. Northern Territory Government, Department of Health and Community Services; 2004 April;
  15. Illinois Institute of Technology. The Delphi Method. Available at: <http://www.iit.edu/∼it/delphi.html> [accessed 22.01.08].
  16. Du Mont J, Macdonald S, Rotbard N, Asllani E, Bainbridge D, Cohen MM. Suspected drug-facilitated sexual assault. CMAJ. 2009;180:513–519
  17. Mayntz-Press KA, Sims LM, Hall A, Ballantyne J. Y-STR profiling in extended interval (> or =3 days) postcoital cervicovaginal samples. J Forensic Sci. 2008;53:342–348
  18. Du Mont J, White D. Uses and impacts of medico-legal evidence in sexual assault cases: a global review. Geneva: World Health Organization; 2007;
  19. Cybulska B. Sexual assault: key issues. J R Soc Med. 2007;100:321–324
  20. Allard JE. The collection of data from findings in cases of sexual assault and the significance of spermatozoa on vaginal, anal and oral swabs. Sci Justice. 1997;37:99–108
  21. Juhascik MP, Negrusz A, Faugno D, et al. An estimate of the proportion of drug-facilitation of sexual assault in four U.S. localities. J Forensic Sci. 2007;52:1396–1400
  22. Brooks KE, Smith NB. A reference method for plasma lactate. Clin Biochem. 1994;27:213–214
  23. Paul BD, Mell LD, Mitchell JM, McKinley RM, Irving J. Detection and quantitation of urinary 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid, a metabolite of tetrahydrocannabinol, by capillary gas chromatography and electron impact mass fragmentography. J Anal Toxicol. 1987;11:1–5
  24. Giesbrecht E, Verjee Z. Detection of gamma-hydroxy butyrate in urine and serum by GC-FID. Ther Drug Monit. 1999;21:470
  25. Smith NB. Determination of volatile alcohols and acetone in serum by non-polar capillary gas chromatography after direct sample injection. Clin Chem. 1984;30:1672–1674
  26. Centre of Forensic Sciences Biology Section . Short tandem repeat (STR) multiplex protocol. Toronto: Centre of Forensic Sciences; 2006;
  27. Yoshida K, Sekiguchi K, Mizuno N, et al. The modified method of two-step differential extraction of sperm and vaginal epithelial cell DNA from vaginal fluid mixed with semen. Forensic Sci Int. 1995;72:25–33
  28. Hurley M, Parker H, Wells DL. The epidemiology of drug facilitated sexual assault. J Clin Forensic Med. 2006;13:107–111
  29. Hall JA, Moore CBT. Drug facilitated sexual assault – a review. Forensic Leg Med. 2008;15:291–297
  30. Scott-Ham M, Burton F. Toxicological findings in cases of alleged drug-facilitated sexual assault in the United Kingdom over a 3-year period. J Clin Forensic Med. 2005;12:175–186
  31. Reiter A, Hake J, Meissner C, Rohwer J, Friedrich HJ, Oehmichen M. Time of drug elimination in chronic drug abusers. Case study of 52 patients in a "low-step" detoxification ward. Forensic Sci Int. 2001;119:248–253
  32. Phillips SD. Drug testing in the workplace. In:  Ford MD,  Delaney KA,  Ling LJ,  Erickson T editor. Clinical toxicology. Philadelphia: WB Saunders; 2001;p. 127–136
  33. Gustafson RA, Kim I, Stout PR, et al. Urinary pharmacokinetics of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol after controlled oral Δ9-tetrahydrocannabinol administration. J Anal Toxicol. 2004;28:160–167
  34. Silverman EM, Silverman AG. Persistence of spermatozoa in the lower genital tracts of women. JAMA. 1978;240:1875–1877
  35. Rogers D, Newton M. Evidence-based forensic sampling – more questions than answers. J Clin Forensic Med. 2006;13:162–163

PII: S1752-928X(10)00083-1

doi: 10.1016/j.jflm.2010.05.004

Journal of Forensic and Legal Medicine
Volume 17, Issue 6 , Pages 333-338 , August 2010

Article Tools

* Image Usage & Resolution